NCT03520439 Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Status COMPLETED Phase PHASE2/PHASE3
NCT03508635 CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Status COMPLETED Phase PHASE1
NCT03269279 Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso Status UNKNOWN Phase PHASE3
NCT03258372 Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites Status COMPLETED Phase PHASE1
NCT03248713 Glucocorticoid Antagonist Treatment for Tobacco Use Disorder Status TERMINATED Phase EARLY_PHASE1
NCT03225547 Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer Status TERMINATED Phase PHASE2
NCT03212352 Comparing Two Medical Treatments for Early Pregnancy Failure. Status TERMINATED Phase PHASE4
NCT03044093 Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion Status UNKNOWN Phase PHASE4
NCT02989662 INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers Status COMPLETED Phase PHASE1/PHASE2
NCT02985229 Acceptability and Feasibility of Medical Abortion in Singapore Status COMPLETED Phase PHASE3
NCT02981030 Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine Status COMPLETED Phase PHASE4
NCT02788981 Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02745093 Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Status UNKNOWN Phase PHASE4
NCT02720991 A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks Status COMPLETED Phase PHASE4
NCT02708446 A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion Status UNKNOWN Phase PHASE4
NCT02704481 Non-surgical Alternatives to Treatment of Failed Medical Abortion Status TERMINATED Phase PHASE4
NCT02679092 Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks Status WITHDRAWN Phase NA
NCT02651844 Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B. Status COMPLETED Phase NA